poisar

Stocks · News reference

8-K filing — Boundless Bio, Inc. (BOLD)

SEC EDGARSEC EDGAR

Filed: 2026-08-28 AccNo: 0001193125-26-374787 Size: 320 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
edgar
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. BenzingaBenzinga Newsdesk

    Boundless Bio Q2 EPS $(1.06) Misses $(0.61) Estimate

    Boundless Bio (NASDAQ:BOLD) reported quarterly losses of $(1.06) per share which missed the analyst consensus estimate of $(0.61) by 73.77 percent. This is a 51.43 percent decrease over losses of $(0.70) per share from